Biofrontera Inc reports results for the quarter ended in September - Earnings Summary

Biofrontera

14/11/2022 18:17

* Biofrontera Inc  BFRI.OQ  reported a quarterly adjusted
loss
of 11 cents​​ per share for the quarter ended in September. The
mean expectation of two analysts for the quarter was for a loss
of 29 cents per share.
    * Revenue fell 0.3% to $4.32 million from a year ago;
analysts
expected $4.31 million. 
    * Biofrontera Inc's reported EPS for the quarter was a loss
of 11
cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Biofrontera Inc shares had fallen by 4.8% this quarter and
lost 86.7% so far this year.
    * The company reported a quarterly loss of $2.66 million.
    * Wall Street's median 12-month price target for Biofrontera
Inc
is $15.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 06:17 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.29          -0.11          Beat
 Jun. 30 2022      -0.34          -0.05          Beat
 Mar. 31 2022      -0.16          -0.18          Missed
 Dec. 31 2021      -0.18          -0.15          Beat